ArticleLipids in health and disease2025
Exploring the associations of the triglyceride‒glucose index with thyroid function in subclinical hypothyroid patients: a cross-sectional study.
Article in Lipids in health and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Cardiometabolic Outcomes and Levothyroxine Treatment Effects in Subclinical Hypothyroidism: A Systematic Review.Cureus · 2026Review
- Integrating Fetuin-A and Lipid-Based Phenotyping as Markers of Cardiometabolic Risk in Subclinical Hypothyroidism.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2026Article
- Impact of iron chelation therapy on thyroid function in beta-thalassemia major patients from Pakistan.Scientific reports · 2026Article
- Non-linear associations of the triglyceride-glucose index with thyroid function in a large Chinese population: a cross-sectional study.Frontiers in nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSubclinical hypothyroidism (SCH) often occurs in association with the emergence of the metabolic disorder like insulin resistance (IR). This study aimed to determine the relationship between the Triglyceride Glucose (TyG) index and thyroid function in patients with subclinical hypothyroidism (SCH), to identify metabolic predictors of thyroid dysfunction.
methodsThis cross-sectional study used convenience sampling, and data were collected after written informed consent. This study was conducted at tertiary care hospitals in Peshawar, Pakistan, and included 2024 subclinical hypothyroid patients with an age > 19 years. Individuals with any thyroid condition, diabetes, cardiovascular disorders or chronic liver conditions were excluded. Regression, ANOVA, and long short-term memory (LSTM) models were used to predict the TyG index, TSH, T3, and FT4 levels. All analyses were performed using R version 4.3.0 and Python. The result was considered statistically significant with P < 0.05.
resultsThe male-to-female ratio was 1:2, and the highest group included 41 50-year-olds (40.3%). Regression analysis revealed an inverse association between the TyG index and T3 level (β = -0.313, P < 0.0001) and a positive association with HbA1c (β = 0.198; P < 0.0001), indicating a relationship between a higher TyG index and IR and poor glycemic control. The values of HDL were negatively correlated with the TyG index (β = -0.221, P < 0.0001); conversely, LDL was positively correlated to TyG (β = 0.234, P < 0.0001). The LSTM model presented high predictive accuracy with small mean squared errors, 0.00034 for the TyG index, 0.0015 for T3, and 0.0113 for T4.
conclusionThe findings of this study demonstrated that the TyG index can be an effective and important parameter of metabolic health and a predictor of thyroid function in subclinical hypothyroid patients. These findings underscore the importance of early identification of metabolic risk factors for thyroid dysfunction, which can contribute to improved health outcomes and reduce the long-term burden of endocrine and cardiovascular diseases at the population level. Moreover, the results of the current research cannot be generalized, as it is a cross-sectional study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.